Temisis Therapeutics announced that it has received €1.6 million in a round of funding on December 18, 2020. The transaction included participation from returning investor Plant Advanced Technologies SA (ENXTPA:ALPAT) and new investor Financiere Hoche Bains-Les-Bains SA (ENXTPA:MLHBB). As part of the transaction, Financiere Hoche Bains-Les-Bains SA (ENXTPA:MLHBB) acquired 1.54% stake in the company and Plant Advanced Technologies SA (ENXTPA:ALPAT) now holds 98.46% in the company.